ReviewJournal of feline medicine and surgery2025
Feline enteropathogens and molecular diagnostics: benefits, limitations and clinical applications.
Review in Journal of feline medicine and surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Practical relevanceFeline enteric disease is a commonly encountered presentation in clinical practice. Interpretation of the clinical relevance of enteropathogens is often misunderstood and can lead to inappropriate case management or overtreatment.Clinical challengesThe approaches to enteric disease, and the enteropathogens responsible, have proven to be an ever-emerging and challenging area within feline medicine. There are often many difficulties regarding diagnosis, interpretation of results and indications to treat. It is important to understand the aetiopathogenesis of disease, population predispositions and the principles underlying diagnostic testing, including its benefits and limitations, to appropriately manage these cases in clinical practice. Diagnostic testing and treatment should be carried out in a targeted manner only where indicated to do so.Evidence baseThis review provides extensive summaries of the most pertinent feline enteropathogens and diagnostic methods available, as well as their limitations, with a particular focus on molecular testing. The authors have provided their substantiated opinion on how best to approach these cases.Global importanceAn enhanced understanding of feline enteric disease is required not only for improved management of these veterinary patients but also particularly relates to the critical topic of antibiotic stewardship and judicious use of antibiotics, which form the mainstay of treatment for many enteropathogens, but are often used inappropriately in healthy cats testing positive for organisms that are not implicated in enteric disease.AudienceThe target audience for this review encompasses general and specialist practitioners, alongside researchers within this field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.